
Nutriband and Kindeva Complete Scale-Up for Abuse-Deterrent Fentanyl Patch
Nutriband Inc., a developer of prescription transdermal pharmaceutical products, has completed commercial manufacturing process scale-up for its lead asset, Aversa™ Fentanyl, in collaboration with Kindeva, a global CDMO focused on drug-device combination products. The product integrates Nutriband’s Aversa™ abuse-deterrent technology